| Literature DB >> 29982273 |
Elizabeth C Oelsner1,2, Pallavi P Balte1, Patricia A Cassano3, David Couper4, Paul L Enright5, Aaron R Folsom6, John Hankinson7, David R Jacobs6, Ravi Kalhan8, Robert Kaplan9, Richard Kronmal10, Leslie Lange11, Laura R Loehr12, Stephanie J London13, Ana Navas Acien14, Anne B Newman15, George T O'Connor16, Joseph E Schwartz17,18, Lewis J Smith8, Fawn Yeh19, Yiyi Zhang1, Andrew E Moran1, Stanford Mwasongwe20, Wendy B White21, Sachin Yende22, R Graham Barr1,2.
Abstract
Chronic lower respiratory diseases (CLRDs) are the fourth leading cause of death in the United States. To support investigations into CLRD risk determinants and new approaches to primary prevention, we aimed to harmonize and pool respiratory data from US general population-based cohorts. Data were obtained from prospective cohorts that performed prebronchodilator spirometry and were harmonized following 2005 ATS/ERS standards. In cohorts conducting follow-up for noncardiovascular events, CLRD events were defined as hospitalizations/deaths adjudicated as CLRD-related or assigned relevant administrative codes. Coding and variable names were applied uniformly. The pooled sample included 65,251 adults in 9 cohorts followed-up for CLRD-related mortality over 653,380 person-years during 1983-2016. Average baseline age was 52 years; 56% were female; 49% were never-smokers; and racial/ethnic composition was 44% white, 22% black, 28% Hispanic/Latino, and 5% American Indian. Over 96% had complete data on smoking, clinical CLRD diagnoses, and dyspnea. After excluding invalid spirometry examinations (13%), there were 105,696 valid examinations (median, 2 per participant). Of 29,351 participants followed for CLRD hospitalizations, median follow-up was 14 years; only 5% were lost to follow-up at 10 years. The NHLBI Pooled Cohorts Study provides a harmonization standard applied to a large, US population-based sample that may be used to advance epidemiologic research on CLRD.Entities:
Mesh:
Year: 2018 PMID: 29982273 PMCID: PMC6211239 DOI: 10.1093/aje/kwy139
Source DB: PubMed Journal: Am J Epidemiol ISSN: 0002-9262 Impact factor: 4.897